GSK (GSK) AIQ Analysis
GSK AIQ Score is 65/100 for investment merit, while Smart Score is 9/10 for peer-relative ranking, with Sharpe 0.93.
Last updated: Jun 1, 2026, 12:00 AM UTC
AIQ Brief
GSK is currently in a mixed setup with AIQ 65/100 and Smart 9/10 (strong relative) at $49.00. Risk is moderate. Read this as a prioritization signal, then confirm entry quality and sizing with your own risk plan.
Quality is the strongest contributor at 81/100, while Risk is the binding constraint at 52/100. With a 29-point spread, the profile is imbalanced, so patience and entry discipline are more important than speed.
GSK ranks 4/4 in this peer set (65 vs peer average 67.3). On risk-adjusted efficiency, Sharpe is below peer average (0.93 vs 1.63). This helps distinguish true relative leadership from broad sector drift.
Action now: this is a neutral/selective setup. Improve entry quality by waiting for momentum acceleration or a better risk profile before adding. Keep sizing moderate until factors align.
Sharpe is 0.93, indicating modest risk-adjusted return.
| AIQ Component | Score | Signal Read |
|---|---|---|
| Momentum | 54 | Mixed trend quality with uneven follow-through. |
| Value | 66 | Valuation appears close to fair value. |
| Quality | 81 | Profitability and consistency profile is strong. |
| Risk | 52 | Risk profile is moderate and manageable. |
| Sentiment | — | Sentiment signal is currently unavailable. |
Current AIQ Read
GSK currently screens as neutral. Wait for confirmation from trend quality and risk conditions before increasing exposure.
Loading GSK analysis...